Pharmacovigilance Practice

Good Pharmacovigilance Practices (GVP) begins with the acquisition of complete information from spontaneous adverse event reports. Good Pharmacovigilance Practice and Pharmacoepidemiology in Risk Management is mainly to increase the probability of beneficial effects of a drug in a population than the probability of adverse effects The pharmacovigilance and clinical trials services providing corporations ought to have the Pharmacovigilance certification.
 
To know more details visit the link: Pharmacovigilance Conference

  • Good reporting practices
  • Interpreting safety signals

Related Conference of Pharmacovigilance Practice

October 23-24, 2025

21st Annual Meet on Pharmaceutical Sciences

Paris, France
November 11-12, 2025

6th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
November 13-14, 2025

21st International Conference on Pharmaceutical Chemistry

Aix-en-Provence, France
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Paris, France
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
December 30-31, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy

Pharmacovigilance Practice Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in